Related Experiment Video
Updated: Apr 8, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Suramin inhibits chikungunya virus replication through multiple mechanisms
Irina C Albulescu1, Marcella van Hoolwerff1, Laura A Wolters1
1Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
The anti-parasitic drug suramin effectively inhibits Chikungunya virus (CHIKV) RNA synthesis and replication in cell cultures. This discovery offers a potential new therapeutic avenue for treating CHIKV infections, as suramin is an already approved medication.
Area of Science:
- Virology
- Drug Discovery
- Immunology
Background:
- Chikungunya virus (CHIKV) is a mosquito-borne alphavirus causing severe, persistent arthritis.
- Millions infected globally, yet no registered antivirals exist.
- Existing antivirals targeting RNA polymerase lack cross-resistance with suramin.
Purpose of the Study:
- To identify potential antiviral agents against CHIKV.
- To investigate the mechanism of action of suramin against CHIKV.
- To evaluate suramin's efficacy in cell culture and against related viruses.
Main Methods:
- Utilized a recently established in vitro assay to screen for CHIKV inhibitors.
- Assessed suramin's inhibition of CHIKV RNA synthesis (IC50) and replication (EC50).
- Performed time-of-addition studies and analyzed CHIKV mutants for drug resistance.
Main Results:
- Suramin demonstrated potent inhibition of CHIKV RNA synthesis (IC50 ∼5μM) and replication (EC50 ∼80μM).
- Suramin showed activity against Sindbis virus and Semliki Forest virus.
- Evidence suggests suramin interferes with RNA synthesis initiation and potentially viral entry.
Conclusions:
- Suramin exhibits significant antiviral activity against CHIKV, with a distinct mechanism of action.
- Its approved status warrants further investigation for CHIKV prevention and treatment.
- Suramin-related compounds and liposomal formulations also show promise.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Arboviral Encephalitis
Inhibitors of Bacterial DNA Synthesis

